
Shinva Medical Instrument Co., Ltd.
SSE:600587.SS
15.5 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 10,020.619 | 10,011.868 | 9,281.769 | 9,482.199 | 9,150.96 | 8,766.761 | 10,283.639 | 9,983.246 | 8,364.496 | 7,554.444 | 6,283.467 | 4,193.764 | 3,035.561 | 2,106.132 | 1,342.233 | 885.837 | 654.964 | 528.909 | 483.165 | 415.249 | 299.424 | 275.192 | 249.648 | 179.942 | 131.797 | 73.055 |
Cost of Revenue
| 7,409.687 | 7,304.704 | 6,827.779 | 7,182.655 | 7,020.901 | 6,905.44 | 8,227.413 | 8,001.502 | 6,625.781 | 5,872.169 | 4,844.155 | 3,232.827 | 2,343.829 | 1,626.631 | 1,017.525 | 653.03 | 490.905 | 400.051 | 364.741 | 320.997 | 218.497 | 198.378 | 175.23 | 120.95 | 85.656 | 44.768 |
Gross Profit
| 2,610.931 | 2,707.164 | 2,453.989 | 2,299.543 | 2,130.06 | 1,861.321 | 2,056.226 | 1,981.744 | 1,738.715 | 1,682.275 | 1,439.312 | 960.937 | 691.732 | 479.501 | 324.709 | 232.806 | 164.059 | 128.858 | 118.424 | 94.253 | 80.927 | 76.814 | 74.418 | 58.992 | 46.141 | 28.287 |
Gross Profit Ratio
| 0.261 | 0.27 | 0.264 | 0.243 | 0.233 | 0.212 | 0.2 | 0.199 | 0.208 | 0.223 | 0.229 | 0.229 | 0.228 | 0.228 | 0.242 | 0.263 | 0.25 | 0.244 | 0.245 | 0.227 | 0.27 | 0.279 | 0.298 | 0.328 | 0.35 | 0.387 |
Reseach & Development Expenses
| 436.084 | 443.365 | 401.274 | 295.98 | 197.533 | 164.082 | 124.879 | 156.618 | 121.671 | 87.71 | 86.361 | 56.615 | 36.246 | 24.604 | 27.614 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 129.015 | 177.284 | 148.65 | 120.147 | 119.256 | 148.065 | 170.047 | 175.167 | 137.234 | 118.412 | 82.992 | 70.58 | 58.181 | 40.176 | 27.587 | 58.302 | 40.808 | 34.512 | 28.756 | 29.725 | 70.476 | 19.644 | 20.028 | 16.067 | 13.537 | 7.745 |
Selling & Marketing Expenses
| 287.659 | 904.138 | 887.469 | 901.922 | 906.317 | 932.215 | 850.76 | 774.372 | 688.413 | 562.248 | 466.783 | 334.278 | 257.286 | 201.38 | 147.412 | 114.238 | 85.657 | 62.889 | 57.083 | 42.261 | 37.805 | 32.49 | 24.974 | 18.331 | 13.34 | 5.64 |
SG&A
| 416.674 | 1,516.505 | 1,036.119 | 1,022.069 | 1,025.573 | 1,080.281 | 1,020.807 | 949.539 | 825.648 | 680.66 | 549.775 | 404.858 | 315.467 | 241.556 | 175 | 172.54 | 126.465 | 97.401 | 85.839 | 71.986 | 108.281 | 52.134 | 45.002 | 34.398 | 26.877 | 13.384 |
Other Expenses
| 959.657 | -9.659 | 323.013 | 310.081 | 287.48 | 279.279 | -5.893 | 14.95 | 100.237 | 95.239 | 43.085 | 33.159 | 7.727 | 11.151 | 3.938 | 2.387 | 8.105 | 11.516 | 5.873 | 6.869 | 4.897 | 4.208 | 2.151 | 1.644 | 1.299 | 0.676 |
Operating Expenses
| 1,812.414 | 1,950.211 | 1,760.407 | 1,628.129 | 1,510.586 | 1,523.642 | 1,425.827 | 1,387.897 | 1,277.165 | 1,106.493 | 865.234 | 612.043 | 454.1 | 328.84 | 243.32 | 178.728 | 129.986 | 100.247 | 88.596 | 73.822 | 109.521 | 53.621 | 46.385 | 35.333 | 27.728 | 14.068 |
Operating Income
| 798.517 | 756.953 | 585.833 | 720.186 | 650.933 | 1,122.613 | 249.029 | 267.725 | 107.897 | 383.488 | 455.592 | 297.378 | 213.075 | 133.813 | 74.25 | 50.321 | 28.789 | 16.223 | 26.159 | 18.536 | -24.624 | 28.482 | 26.019 | 23.972 | 19.051 | 13.458 |
Operating Income Ratio
| 0.08 | 0.076 | 0.063 | 0.076 | 0.071 | 0.128 | 0.024 | 0.027 | 0.013 | 0.051 | 0.073 | 0.071 | 0.07 | 0.064 | 0.055 | 0.057 | 0.044 | 0.031 | 0.054 | 0.045 | -0.082 | 0.103 | 0.104 | 0.133 | 0.145 | 0.184 |
Total Other Income Expenses Net
| -2.856 | -18.374 | -9.74 | -2.157 | -19.519 | -1.985 | -9.846 | 14.95 | -216.757 | 94.285 | 41.777 | 32.685 | 4.703 | 10.087 | -0.025 | 2.327 | 7.722 | 11.516 | -0.148 | -8.527 | -0.218 | -0.053 | -0.194 | -0.071 | -0.044 | -0.291 |
Income Before Tax
| 795.661 | 738.579 | 576.094 | 718.029 | 345.3 | 1,120.628 | 243.137 | 282.675 | 203.553 | 477.773 | 497.369 | 330.063 | 219.681 | 143.9 | 77.896 | 52.648 | 36.511 | 27.74 | 25.931 | 18.654 | -24.843 | 28.429 | 25.824 | 23.9 | 19.007 | 13.167 |
Income Before Tax Ratio
| 0.079 | 0.074 | 0.062 | 0.076 | 0.038 | 0.128 | 0.024 | 0.028 | 0.024 | 0.063 | 0.079 | 0.079 | 0.072 | 0.068 | 0.058 | 0.059 | 0.056 | 0.052 | 0.054 | 0.045 | -0.083 | 0.103 | 0.103 | 0.133 | 0.144 | 0.18 |
Income Tax Expense
| 103.764 | 62.078 | 46.887 | 162.005 | 105.899 | 260.542 | 120.923 | 133.726 | 82.924 | 115.393 | 106.082 | 63.589 | 38.768 | 26.261 | 13.269 | 8.613 | 6.116 | 4.604 | 4.403 | 3.457 | 2.433 | 4.139 | 4.463 | 5.258 | 7.255 | 4.979 |
Net Income
| 691.61 | 653.997 | 500.072 | 556.494 | 234.139 | 861.315 | 22.784 | 65.529 | 34.636 | 280.834 | 326.441 | 231.68 | 163.311 | 107.258 | 60.352 | 41.287 | 29.868 | 22.434 | 20.87 | 15.105 | -28.805 | 24.063 | 21.361 | 18.642 | 11.753 | 8.187 |
Net Income Ratio
| 0.069 | 0.065 | 0.054 | 0.059 | 0.026 | 0.098 | 0.002 | 0.007 | 0.004 | 0.037 | 0.052 | 0.055 | 0.054 | 0.051 | 0.045 | 0.047 | 0.046 | 0.042 | 0.043 | 0.036 | -0.096 | 0.087 | 0.086 | 0.104 | 0.089 | 0.112 |
EPS
| 1.14 | 1.1 | 1.23 | 1.37 | 0.58 | 2.12 | 0.06 | 0.16 | 0.09 | 0.69 | 0.82 | 0.64 | 0.49 | 0.36 | 0.2 | 0.14 | 0.099 | 0.081 | 0.11 | 0.06 | -0.13 | 0.096 | 0.085 | 0.086 | 0.054 | 0.038 |
EPS Diluted
| 1.14 | 1.1 | 1.23 | 1.37 | 0.58 | 2.12 | 0.06 | 0.16 | 0.09 | 0.69 | 0.82 | 0.64 | 0.49 | 0.36 | 0.2 | 0.14 | 0.099 | 0.081 | 0.11 | 0.06 | -0.13 | 0.096 | 0.085 | 0.086 | 0.054 | 0.038 |
EBITDA
| 1,050.691 | 967.714 | 830.365 | 1,024.322 | 661.772 | 1,476.529 | 618.672 | 623.09 | 533.22 | 583.077 | 647.321 | 413.278 | 269.77 | 167.751 | 92.648 | 72.323 | 60.298 | 55.376 | 50.06 | 41.043 | -10.331 | 38.778 | 34.817 | 30.933 | 20.208 | 14.219 |
EBITDA Ratio
| 0.105 | 0.097 | 0.089 | 0.108 | 0.072 | 0.168 | 0.06 | 0.062 | 0.064 | 0.077 | 0.103 | 0.099 | 0.089 | 0.08 | 0.069 | 0.082 | 0.092 | 0.105 | 0.104 | 0.099 | -0.035 | 0.141 | 0.139 | 0.172 | 0.153 | 0.195 |